We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Five Breakout Zacks Rank #1 (Strong Buy) Stocks on the Move
Read MoreHide Full Article
Good news on a day where the market just managed to squeak itself in to the green. A major concern for markets a few weeks ago was Trump’s ability to get legislation passed. Skepticism ruled the day and traders were worried that he may not be able to get all these wonderful tax cuts and infrastructure spending plans approved. Today the market really didn’t care that Trump’s budget got eviscerated and Congress passed a bill that essentially kicked the can down the road.
Check out Dave’s Daily Dive video above where he breaks down the market action today!!!
Each day, Dave Bartosiak of Zacks.com (Twitter @bartosiastics) dives into the charts, pointing out key price action and levels for you to watch.
But it doesn’t stop there because the highlight of today’s video, which you can see for free by clicking above, is where Dave uncovers five Zacks Rank #1 (Strong Buy) stocks that are breaking out to new 52-week highs today. These stocks have a ton of momentum behind them and are charging higher. The list of stocks he covers today include:
Aaron’s, Inc. operates an omnichannel provider of lease-purchase solutions. It operates through five segments: Sales and Lease Ownership, Progressive, DAMI, Franchise, and Manufacturing. The company engages in the sale, lease ownership, and specialty retailing of furniture, consumer electronics, home appliances, and accessories. As of February 17, 2017, it operated approximately 1,860 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform.
AGCO CORP. is engaged in the manufacturer and distribution of farm equipment, machinery and replacement parts in the United States and Canada. Products include tractors, combines, hay tools and forage equipment and implements.
Brooks Automation
Brooks Automation, Inc. provides automation and cryogenic solutions for various applications and markets. It operates through two segments, Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum, and contamination controls solutions and services. The Brooks Life Science Systems segment provides automated cold storage systems; consumables, including various formats of racks, tubes, caps, plates and foils; and instruments used for labeling, bar coding, capping, decapping, auditing, sealing, peeling, and piercing tubes and plates.
Century Casinos, Inc. operates as a casino entertainment company worldwide. The company develops and operates gaming establishments, as well as related lodging, restaurant, horse racing, and entertainment facilities. It owns and operates casinos in North America and Poland; a racetrack and entertainment center in Canada; and pari-mutuel off-track betting network in southern Alberta, Canada. The company also manages cruise ship-based casinos and a casino in Aruba; and provides gaming services in Argentina.
Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. The company’s products include CABOMETYX for the treatment of patients with advanced renal cell carcinoma, who have received prior anti-angiogenic therapy; and COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid carcinoma.
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Five Breakout Zacks Rank #1 (Strong Buy) Stocks on the Move
Good news on a day where the market just managed to squeak itself in to the green. A major concern for markets a few weeks ago was Trump’s ability to get legislation passed. Skepticism ruled the day and traders were worried that he may not be able to get all these wonderful tax cuts and infrastructure spending plans approved. Today the market really didn’t care that Trump’s budget got eviscerated and Congress passed a bill that essentially kicked the can down the road.
Check out Dave’s Daily Dive video above where he breaks down the market action today!!!
Each day, Dave Bartosiak of Zacks.com (Twitter @bartosiastics) dives into the charts, pointing out key price action and levels for you to watch.
But it doesn’t stop there because the highlight of today’s video, which you can see for free by clicking above, is where Dave uncovers five Zacks Rank #1 (Strong Buy) stocks that are breaking out to new 52-week highs today. These stocks have a ton of momentum behind them and are charging higher. The list of stocks he covers today include:
Aaron’s (AAN - Free Report)
Aaron’s, Inc. operates an omnichannel provider of lease-purchase solutions. It operates through five segments: Sales and Lease Ownership, Progressive, DAMI, Franchise, and Manufacturing. The company engages in the sale, lease ownership, and specialty retailing of furniture, consumer electronics, home appliances, and accessories. As of February 17, 2017, it operated approximately 1,860 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform.
AGCO Corp (AGCO - Free Report)
AGCO CORP. is engaged in the manufacturer and distribution of farm equipment, machinery and replacement parts in the United States and Canada. Products include tractors, combines, hay tools and forage equipment and implements.
Brooks Automation
Brooks Automation, Inc. provides automation and cryogenic solutions for various applications and markets. It operates through two segments, Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum, and contamination controls solutions and services. The Brooks Life Science Systems segment provides automated cold storage systems; consumables, including various formats of racks, tubes, caps, plates and foils; and instruments used for labeling, bar coding, capping, decapping, auditing, sealing, peeling, and piercing tubes and plates.
Century Casinos (CNTY - Free Report)
Century Casinos, Inc. operates as a casino entertainment company worldwide. The company develops and operates gaming establishments, as well as related lodging, restaurant, horse racing, and entertainment facilities. It owns and operates casinos in North America and Poland; a racetrack and entertainment center in Canada; and pari-mutuel off-track betting network in southern Alberta, Canada. The company also manages cruise ship-based casinos and a casino in Aruba; and provides gaming services in Argentina.
Exelixis (EXEL - Free Report)
Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. The company’s products include CABOMETYX for the treatment of patients with advanced renal cell carcinoma, who have received prior anti-angiogenic therapy; and COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid carcinoma.
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>